Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
NEW YORK (
) hit a new 52-week high Thursday as it is currently trading at $43.24, above its previous 52-week high of $43.18 with 1.1 million shares traded as of 10:40 a.m. ET. Average volume has been 4.2 million shares over the past 30 days.
Medtronic has a market cap of $43.83 billion and is part of the
industry. Shares are up 12% year to date as of the close of trading on Wednesday.
Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company has a P/E ratio of 13.1, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
TheStreet Ratings rates Medtronic as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, increase in net income and notable return on equity. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full
52-week high stocks
or get investment ideas from our
FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge!
Free download now